Register
Medicines reference
Product

Biofel PCH

Feline parvovirus + Feline calicivirus + Feline herpesvirus · Bioveta a.s.

1 form: emulsion. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Emulsion · Cat Cat 1 ml
Inject one 1 ml dose subcutaneously, preferably behind the shoulder blade, from 8 weeks of age regardless of weight or breed. The official course specifies Biofel PCH at 8-10 weeks followed by Biofel PCHR 3 weeks later and not before 3 months; revaccinate with PCHR every 12 months. Vaccinate healthy cats only and treat parasites at least 10 days beforehand. Not recommended during the first half of pregnancy. Because the vaccine contains mineral-oil adjuvant, accidental self-injection is a medical emergency.
· two-dose primary course, then annual PCHR revaccination
two-dose primary course, then annual PCHR revaccination Georgia Yes, veterinary
Details: pack, label wording, sources, registration

Biofel PCH, Emulsion

emulsion for injection, 1 ml dose for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
7.6/10
Good
vetman assessment

Biofel PCH

emulsion for injection, 1 ml dose for cats
Assessed clinical scopeCat · Full cat label: immunisation against panleukopenia, calicivirus and herpesvirus disease within the labelled PCH-to-PCHR primary and annual revaccination programme · Subcutaneous
Care settingPreventive feline vaccination with examination, cold-chain control, injection-site planning and emergency treatment available
vetman score 7.6/10 Good
Evidence confidence: High Georgia: Yes, veterinary · № 70-11 · Verified on 21 Oct 2026

A credible inactivated feline core vaccine with exact regulatory support, but not a best-in-class universal choice: the linked annual PCHR schedule and mineral-oil adjuvant should be weighed against longer-interval and non-adjuvanted alternatives for the individual cat.

Regulatory and scientific credibility8.5/10

The exact product is registered in Georgia and has a valid EU regulator record, current SPC and public assessment report, with transparent inactivated strains, adjuvant and schedule.

Clinical efficacy7.5/10

FPV, FHV and FCV are worldwide core targets and professional guidelines support trivalent vaccination; inactivated FPV products generally produce slower and less durable protection than modified-live options, and FHV/FCV vaccination reduces disease rather than guaranteeing sterile immunity.

Safety and tolerability7.0/10

Inactivated antigen avoids live-vaccine shedding, but the mineral-oil adjuvant adds injection-site burden and accidental self-injection risk; healthy-patient selection, pregnancy restrictions and readiness for hypersensitivity remain important.

Clinical practicality7.0/10

A fixed 1 ml SC dose is straightforward, but a PCH dose followed by PCHR, annual revaccination, cold-chain handling and adjuvanted feline injection-site planning create a meaningful continuing burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Vaccinate healthy cats only; do not use in hypersensitivity to a component.
  • The mineral-oil adjuvant makes accidental self-injection a medical emergency; seek immediate medical advice even if only a very small amount was injected.
  • Use is not recommended during the first half of pregnancy.
  • The labelled primary programme depends on a Biofel PCHR dose three weeks later and not before 3 months of age; PCHR is then repeated annually.
  • Plan a guideline-concordant kitten series through at least 16 weeks when maternal antibody risk remains; the fixed label sequence alone may not cover every kitten response window.
  • Monitor the injection site and general condition after vaccination; have immediate treatment available for hypersensitivity or anaphylaxis.
  • Maintain refrigerated storage, do not freeze and use each opened dose according to the product information.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Feline parvovirus1 RP/dose Feline calicivirus1 RP/dose Feline herpesvirus1 RP/dose
Formulation Type
Emulsion
Administration route
Subcutaneous
Manufacturer
Bioveta a.s. · Czechia
Manufacturer (register)
Bioveta a.s., Czechia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 118, 19 Oct 2026.
Registration
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml
Inject one 1 ml dose subcutaneously, preferably behind the shoulder blade, from 8 weeks of age regardless of weight or breed. The official course specifies Biofel PCH at 8-10 weeks followed by Biofel PCHR 3 weeks later and not before 3 months; revaccinate with PCHR every 12 months. Vaccinate healthy cats only and treat parasites at least 10 days beforehand. Not recommended during the first half of pregnancy. Because the vaccine contains mineral-oil adjuvant, accidental self-injection is a medical emergency.
Cat Any weight Subcutaneous two-dose primary course, then annual PCHR revaccination
EU UPD Biofel PCH
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Biofel PCH - official product information
EU Union Product Database, 2026

Feline parvovirus: No dose supported by a publicly verifiable source yet

Feline calicivirus: No dose supported by a publicly verifiable source yet

Feline herpesvirus: No dose supported by a publicly verifiable source yet

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.